Table 3.

Change of body weight and composition andabdominal fat area measurements at the 0-week and 12-week of the study

¹⁾Values are expressed as means ± SE.

WHR, waist to hip ratio; VSR, Visceral to subcutaneous ratio.

²⁾Values in this column represent the difference between the mean changes scores of the Doenjang group and those of the placebo group;95% CIs are in parentheses.

³⁾Pvalues derived from repeated measures analysis (per protocol) after adjusting for age, gender and BMI.

^*P < 0.05, ^**P < 0.01, ^***P < 0.001 : P-values indicate significant differences in the variables between 0 week and 12 weeks, which were evaluated by the paired t-test.